Dean Petkanas's guest appearances

Dean Petkanas

CEO Interviews

MJBulls: Cannabis investing and cannabis fundraising

Chris Henry

Ben Franklin

Jason Mitchell

Adam Levin

Pete Evans

Michael Cohen

Zev Paiss

Zach Williams

Kevin Brooks

Joe Mechlinski

Michael Johnson

Brent Johnson

David Friedman

Kyle Porter

Michael Scott

OwlTail

   Improving CBD’s aptitude to create a new treatment for patients with significant medical needs. The medical benefits of Cannabidiol (CBD) were most notably confirmed in the U.S. Government Patent 6,630,507 – “Cannabinoids as Antioxidants and Neuroprotectants”.    Kannalife (OTCMKTS: KLFE) received a license to use the patent to conduct research on cannabinoid therapeutics.   Dean Petkanas  speaks to Dan Humiston about their discoveries for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN), Hepatic Encephalopathy (HE), Mild Traumatic Brain Injury (mTBI) and chronic pain management.Produced by PodCONX

Improving CBD’s aptitude to create a new treatment for patients with significant medical needs. The medical benefits of Cannabidiol (CBD) were most notably confirmed in the U.S. Government Patent 6,630,507 – “Cannabinoids as Antioxidants and Neuroprotectants”.    <a href="https://www.kannalife.com/" rel="nofollow" target="_blank">Kannalife</a> (OTCMKTS: KLFE) received a license to use the patent to conduct research on cannabinoid therapeutics.   <a href="https://podconx.com/guests/dean-petkanas" rel="nofollow" target="_blank">Dean Petkanas</a>  speaks to <a href="https://podconx.com/guests/dan-humiston" rel="nofollow" target="_blank">Dan Humiston</a> about their discoveries for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN), Hepatic Encephalopathy (HE), Mild Traumatic Brain Injury (mTBI) and chronic pain management.<a href="https://podconx.com/" rel="nofollow" target="_blank">Produced by PodCONX</a>